Dipeptidyl-Peptidase IV inhibitors and glycemic control in type 2 Diabetes Mellitus

<p><strong>Background &amp; Objectives: </strong>Type 2 diabetes mellitus (T2DM) is a progressive disease, characterized by insulin resistance, impaired glucose-induced insulin secretion, inappropriately elevated glucagon concentrations, and hyperglycemia. Many patients cannot...

Full description

Bibliographic Details
Main Authors: Lokendra Bahadur Sapkota, Sangita Thapa
Format: Article
Language:English
Published: College of Medical Sciences 2016-03-01
Series:Journal of College of Medical Sciences-Nepal
Online Access:http://nepjol.info/index.php/JCMSN/article/view/14684